Eucomed Touts Uniqueness Of Tissue Products In Response To EU Reg
This article was originally published in The Gray Sheet
Executive Summary
Eucomed stresses the differences between human tissue-engineered products (hTEPs) and pharmaceutical products in its June 29 response to a proposed advanced therapy regulation